Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Methods of Documentation VII: EMR01:30

Methods of Documentation VII: EMR

Electronic Medical Records (EMRs) primarily center around electronically documenting patients' health information within a single healthcare organization or practice. They contain essential clinical data related to a patient's medical history, diagnoses, medications, treatment plans, lab results, and other pertinent information relevant to the specific encounter or episode of care. EMRs are designed to streamline documentation and workflow processes within individual healthcare settings,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural language processing tools for non-clinical healthcare management.

Journal of healthcare quality research·2023
Same author

Lung ultrasound in plastic bronchitis.

Medicina intensiva·2021
Same author

Communicating with surgeons.

The British journal of surgery·2021
Same author

Global parental leave in surgical careers: differences according to gender, geographical regions and surgical career stages.

The British journal of surgery·2021
Same author

Impact of a modification of the clinical practice guide of the American Academy of Pediatrics in the management of severe acute bronchiolitis in a pediatric intensive care unit.

Medicina intensiva·2021
Same author

Molecular identification of <i>Leishmania tropica</i> and <i>L. infantum</i> isolated from cutaneous human leishmaniasis samples in central Morocco.

Journal of vector borne diseases·2021
Same journal

[Annual report of Anales de Pediatría editors].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[COVID-19: Critical appraisal of the evidence].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Usefulness of chest ultrasound in a neonatal infection due to SARS-CoV-2].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Cutaneous manifestations in the current pandemic of coronavirus infection disease (COVID 2019)].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[Breastfeeding app updates and recommendations].

Anales de pediatria (Barcelona, Spain : 2003)·2024
Same journal

[The impact of the pandemic on vaccination coverage in Spain: a challenge for pediatrics and public health].

Anales de pediatria (Barcelona, Spain : 2003)·2024
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

[ECMO: experience in paediatrics].

S Segura1, F J Cambra, J Moreno

  • 1Servicio de Cuidados Intensivos Pediátricos, Hospital Sant Joan de Déu-Clínic, Universitat de Barcelona, Esplugues de Llobregat, Barcelona, España. ssegura@hsjdbcn.org

Anales De Pediatria (Barcelona, Spain : 2003)
|January 29, 2009
PubMed
Summary
This summary is machine-generated.

Extracorporeal Membrane Oxygenation (ECMO) offers vital support for pediatric patients with reversible respiratory or cardiac failure. Survival rates are comparable to national data, with no serious sequelae attributed to ECMO in survivors.

More Related Videos

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Experiment Videos

Last Updated: Jun 26, 2026

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Area of Science:

  • Pediatric Critical Care Medicine
  • Cardiopulmonary Support
  • Extracorporeal Life Support

Context:

  • Extracorporeal Membrane Oxygenation (ECMO) is a life-support technology for severe respiratory and/or cardiac failure.
  • Conventional treatments are often insufficient for critically ill pediatric patients.
  • This study reviews ECMO implementation and outcomes in a pediatric intensive care unit.

Purpose:

  • To define institutional criteria for initiating ECMO in pediatric patients.
  • To compare clinical outcomes based on underlying pathology (respiratory failure, congenital heart disease, sepsis).
  • To identify potential sequelae of ECMO in pediatric survivors.

Summary:

  • A retrospective review of 16 pediatric patients (excluding neonates) treated with ECMO between 2001 and 2007.
  • Indications included respiratory failure (11), congenital heart disease (2), and sepsis (3).
  • Overall survival was 50%, with outcomes varying by initial diagnosis. No significant ECMO-related sequelae were observed in survivors.

Impact:

  • ECMO survival rates in this cohort align with established benchmarks (ELSO 2004).
  • Prognosis is significantly influenced by the patient's primary condition.
  • Specific initiation criteria are tailored to the underlying pathology, optimizing ECMO application.